(Q35591583)
Statements
Detection and Dynamic Changes of EGFR Mutations from Circulating Tumor DNA as a Predictor of Survival Outcomes in NSCLC Patients Treated with First-line Intercalated Erlotinib and Chemotherapy (English)
Yi-Long Wu
Jin Soo Lee
Virote Sriuranpong
Jennifer Sandoval-Tan
Guia Ladrera
Sumitra Thongprasert
Vichien Srimuninnimit
Meilin Liao
Yunzhong Zhu
Caicun Zhou
Fatima Fuerte
Benjamin Margono
Wei Wen
Julie Tsai
Matt Truman
Barbara Klughammer
David S Shames